Up-Regulation

Download PDF

Recent Publications on Up-Regulation:
Mechanism of humoral and cellular immune modulation provided by porcine sertoli cells. The understanding of main mechanisms that determine the ability of immune...	28th June, 2008	Xenotransplantation Research Center, Seoul National University, Seoul,	J Korean Med Sci. 2008 Jun;23(3):514-20. DOI Direct Link
Silencing onion lachrymatory factor synthase causes a significant change in the sulfur secondary metabolite profile. Through a single genetic transformation in onion, a crop recalcitrant to...	28th June, 2008	National Centre for Advanced Bio-Protection Technologies, Lincoln	Plant Physiol. 2008 Jun 26;. DOI Direct Link
Superoxide-Dependent Cathepsin Activation Is Associated with Hypertensive Myocardial Remodeling and Represents a Target for Angiotensin II Type 1 Receptor Blocker Treatment. The elastolytic activity of cathepsins in the myocardium is implicated in...	28th June, 2008	From the Department of Cardiovascular Research Medicine,* Nagoya	Am J Pathol. 2008 Jun 26;. DOI Direct Link
Nucleolus, Ribosomes, and Cancer. The complex aspects linking the nucleolus and ribosome biogenesis to...	28th June, 2008	From the Department of Experimental Pathology, University of Bologna,	Am J Pathol. 2008 Jun 26;. DOI Direct Link
[Angiotensin II stimulates platelet-derived growth factor-B expression in hepatic stellate cells by activating EGR-1.] OBJECTIVE: To investigate the signal transduction mechanism underlying the...	28th June, 2008	Departments of Emergency, Nanfang Hospital, Southern Medical University,	Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28(6):963-7.
→View more research publications.

BioNews Results for Up-Regulation:
New England Journal of Medicine and the Lancet Publish Results from Landmark Rivaroxaban Studies	Pharma Live:  Jun 28 2008 5:19AM Matching: regulation
Thermo Fisher Scientific Elects New Director	DiGiTAL50:  Jun 28 2008 6:42AM Matching: regulation
Lorus Therapeutics Files Final Prospectus for Rights Offering to Shareholders	Pharma Live:  Jun 27 2008 8:17PM Matching: regulation
Health Unions respond to the Nursing and Midwifery Council's reorganisation	Royal College of Nursing:  Jun 27 2008 7:25PM Matching: regulation
Key Challenges and Issues Facing the Chinese Pharmaceutical Outlook 2008-2023	Houston Chronicle:  Jun 25 2008 11:58PM Matching: regulation
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Up-Regulation Clinical Trials:
Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation	Allergic Rhinitis;   Tachyphylaxis;   Rhinitis Medicamentosa
Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer	Head and Neck Cancer
Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF and Rituximab
The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood	Herpes Simplex;   HIV Infections
The Influence of Rosiglitazone on the Diuretic Effect of Furosemide and Amiloride	Insulin Resistance
→View more trials.

Up-Regulation Patents:
US Patent No.	Title
7378495	PTH-rP related peptide cancer therapeutics
7381810	Polyphenol oxidase genes from lettuce
7381863	Soybean variety XB27K06
7381865	Soybean Variety 98R31
7384635	Protein variants of naturally occurring allergens
→View more patents.

Companies working in the area of Up-Regulation from Bioportfolio's Biocorporate database :
Company Name
Replicon Technologies Incorporated Replicon Technologies, Inc. (RTI) is an emerging biotechnology company focused on the use of replicons, non-replicating RNA viral particles, for the treatment of patients with cancer. RTI is founded... www.replicontechnologies.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Up-Regulation scientists - we have details of around 5026 individuals working on Up-Regulation .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.